InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (20 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
20
T+90 hit rate
0%
T+90 mean return
-6.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by FORMELA JEAN FRANCOIS. Director active across 4 companies, notably Intellia Therapeutics, Inc.. In total, 27 disclosures have been published. Breakdown: 2 buys · 20 sells. Total volume traded: €146.7m. Activity tracked since 11 June 2021. The latest transaction was filed on 2 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations27 total
85,955 shares@ US$14.030.59% mcap45.4% of flowCommon StockSEC:0001030575-26-000006:0
14,745 shares@ US$14.030.10% mcap7.8% of flowCommon StockSEC:0001030575-26-000006:1
817 shares@ US$13.960.0056% mcap0.4% of flowCommon StockSEC:0001030575-26-000006:2
8,506 shares@ US$13.960.058% mcap4.5% of flowCommon StockSEC:0001030575-26-000006:3
3,382 sharesCommon StockSEC:0001030575-26-000004:0
580 sharesCommon StockSEC:0001030575-26-000004:1
101,579 sharesCommon StockSEC:0001030575-26-000004:2
17,426 sharesCommon StockSEC:0001030575-26-000004:3
40,679 sharesCommon StockSEC:0001030575-26-000004:4
666 sharesCommon StockSEC:0001030575-26-000004:5
6,979 sharesCommon StockSEC:0001030575-26-000004:6
114 sharesCommon StockSEC:0001030575-26-000004:7
2,441 shares@ US$13.953.0% of flowCommon StockSEC:0001030575-26-000002:0
419 shares@ US$13.950.5% of flowCommon StockSEC:0001030575-26-000002:1
17,857 shares@ US$56.0096.5% of flowCommon StockSEC:0001415889-24-011388:0
942,075 sharesCommon StockSEC:0000950170-23-060597:0
5,197 shares0Common StockSEC:0001209191-22-037598:0
125,000 shares@ US$16.0050.0% of flowCommon StockSEC:0001209191-21-069645:0
Ideal exit: 25 Dec 2021 (T+270)
125,000 shares@ US$16.0050.0% of flowCommon StockSEC:0001209191-21-069645
Ideal exit: 25 Dec 2021 (T+270)
2,055,063 shares@ US$38.0050.0% of flowCommon StockSEC:0001209191-21-056045:0
2,055,063 shares@ US$38.0050.0% of flowCommon StockSEC:0001209191-21-056045
26,019 shares@ US$127.0228.8% of flowCommon StockSEC:0001104659-21-086607
26,019 shares@ US$127.020.15% mcap28.8% of flowCommon StockSEC:0001104659-21-086607:0
2,094 shares0Common StockSEC:0001209191-21-043374
2,094 shares0Common StockSEC:0001209191-21-043374:0
25 of 27 declarations
About FORMELA JEAN FRANCOIS
FORMELA JEAN FRANCOIS is a director at Intellia Therapeutics, Inc. and also holds insider roles at Translate Bio, Inc. and Ikena Oncology, Inc.
